Rainbow Coral Corp (RBCC) 0.1530 $RBCC
RBCC: Customized Pills Show the Power and Potential of Personalized Medicine
ACCESSWIRE - Thu Jun 02, 7:27AM CDT
HENDERSON, NV / ACCESSWIRE / June 2, 2016 / Rainbow Coral Corp. (OTCQB: RBCC) continues to seek new opportunities and breakthroughs in personalized medicine and recent news from Singapore could offer the company the ground floor chance it has been looking for to become a leader in this rapidly growing field.
Upcoming Opioid Addiction Action in Congress Could Mean Opportunities for RBCC
ACCESSWIRE - Mon May 23, 4:01AM CDT
HENDERSON, NV / ACCESSWIRE / May 23, 2016 / Spurred by the ever-growing opioid addiction crisis, the U.S. Congress is now busy refining bipartisan legislation aimed at providing help and relief for those hooked on prescription drugs. This prospect could bode well for Rainbow Coral Corp. (OTCQB: RBCC) as it develops a new addiction treatment program utilizing Naltrexone, an anti-addiction medication.
Independent Forecast Justifies RBCC's Focus on Booming Personalized Medicine Market
ACCESSWIRE - Mon May 09, 9:04AM CDT
HENDERSON, NV / ACCESSWIRE / May 9, 2016 / Personalized (or precision) medicine continues a surge that shows no signs of stopping, and according to an independent research report the total market could top $88 billion within six years. The glowing report comes as welcome news for Rainbow Coral Corp. (OTCQB: RBCC), which has been active on several personalized medicine fronts recently, and bolsters the company's ambitions to someday be a leader in the field.
U.S. Drug Overdose Deaths Hit Record High, Opening Door for RBCC to Offer Solutions
ACCESSWIRE - Wed Apr 27, 4:00AM CDT
HENDERSON, NV / ACCESSWIRE / April 27, 2016 / Recently released overdose mortality statistics paint a grim picture of America's battle against prescription drug addiction, and while the portrait isn't pretty, Rainbow Coral Corp. (OTCQB: RBCC) believes the dire numbers may have at last spurred industry and government to find a workable answer.
RBCC Hails NYC Mayor's Bid to End the Big Apple's Opioid Addiction, Offers Assistance
BusinessWire - Wed Feb 10, 4:00AM CST
Rainbow Coral Corp. (OTCQB: RBCC) wants New York Mayor Bill De Blasio and his wife, Chirlane McCray, to know it's ready with an ample supply of Naltrexone to help their efforts to eradicate opioid addiction in America's biggest metropolis.
RBCC: Drug Approvals Show Personalized Medicine Gaining Favor with Feds and Public
BusinessWire - Thu Feb 04, 8:22AM CST
Rainbow Coral Corp. (OTCQB: RBCC) expects personalized medicine to grow even faster after examining the Federal Drug Administration's (FDA) list of drug approvals in 2015 - a list that includes a high percentage of pharmaceuticals intended for that rapidly rising market.
RBCC: Survey Shows Teen Substance Abuse Falling, But Much Work Remains
BusinessWire - Thu Jan 28, 8:06AM CST
Rainbow Coral Corp. (OTCQB: RBCC) is hailing a recent nationwide survey that shows substance abuse and addiction among American teens has dropped, but the company says a lot of hard work still lies ahead before the current crisis can be considered over.
Where Are We Headed - New Reports on World Moto, Greengro Technologies, Rainbow Coral, and Estacio Participacoes
ACCESSWIRE - Tue Jan 19, 8:16AM CST
NEW YORK, NY / ACCESSWIRE / January 19, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: World Moto Inc. (OTC: FARE), Greengro Technologies Inc. (OTC: GRNH), Rainbow Coral Corp. (OTC: RBCC) and Estacio Participacoes SA (OTC: ECPCY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Dynamics Driving Stunning Growth of Personalized Medicine Bode Well for RBCC
BusinessWire - Tue Jan 19, 4:00AM CST
A prominent doctor and healthcare expert says three key factors will drive continued future growth in personalized medicine and these elements spell opportunity for Rainbow Coral Corp. (OTCQB: RBCC) as it ramps up its efforts in this increasingly important field.
RBCC: Report Shows Personalized Medicine Market to More Than Double by 2022
BusinessWire - Wed Jan 13, 4:01AM CST
Rainbow Coral Corp. (OTCQB:RBCC) continues focusing on the personalized medicine market and expects its efforts to increase now that a prominent research study indicates the segment will grow to a nearly $2.5 billion industry by 2022. That figure represents almost a 150 percent increase in the market's current size of $1 billion in just a six-year period.
RBCC Aims to Increase Focus on Real 'Gateway Drug' Plaguing North America
BusinessWire - Mon Jan 11, 4:00AM CST
Rainbow Coral Corp. (OTCQB: RBCC) believes lawmakers and politicians have lost sight of a drug that far too often leads users to abuse and addiction, and unlike substances candidates and activists rail against, this one is perfectly legal.
RBCC Makes Great Strides in 2015, Looks Ahead to Eventful New Year
BusinessWire - Wed Jan 06, 4:22AM CST
Rainbow Coral Corp. (OTCQB:RBCC) President and CEO Kimberly Palmer issued the following open letter to stockholders today, reviewing the Company's 2015 achievements and providing a peek at what's to come in 2016:
RBCC: Need Grows for Affordable Treatment as Opioid Overdose Deaths Outpace Heroin
BusinessWire - Tue Dec 29, 7:21AM CST
Rainbow Coral Corp. (OTCQB: RBCC) intends to make 2016 a year where a sizable dent is finally made in the ongoing crisis concerning the alarming rate of opioid overdose deaths in the U.S. The company has already begun a search for partners and a location to open an inclusive, low-cost opioid addiction treatment center, and RBCC continues to explore options to obtain additional capital to fund such centers and other important anti-addiction research.
RBCC to Target Massive New Venture Capital Pouring Into American Healthcare
BusinessWire - Thu Dec 17, 8:28AM CST
A record amount of venture capital is flowing into the U.S. healthcare system. Rainbow Coral Corp. (OTCQB: RBCC) sees this influx as reaffirming its forward-looking personalized medicine strategy and plans to go after additional seed money to expand its market presence.
RBCC Offers Solutions to Growing Opioid Addiction Crisis That Kills 44 People per Day
BusinessWire - Mon Nov 23, 4:00AM CST
Rainbow Coral Corp. (OTCQB:RBCC) is heeding an urgent call to action put out by a prominent group of medical scientists looking to end the nation's expanding prescription opioid addiction epidemic - a problem that is now claiming an average of 44 lives per day.
RBCC Excited About Rapid Advances in Bioprinting
BusinessWire - Mon Nov 16, 4:00AM CST
Rainbow Coral Corp. (OTCQB:RBCC) and partner Nano3D Biosciences (n3D) are pondering potential future moves as researchers make tremendous strides in the field of bioprinting, meaning it may soon be possible to use additive manufacturing technology to engineer an entire human body.
RBCC Maps Out Strategy to Curb Addiction in Canada's Indigenous Communities
BusinessWire - Mon Nov 02, 4:00AM CST
Rainbow Coral Corp. (OTCBB: RBCC) has begun working on a way to increase use of the anti-addiction drug Naltrexone as well as to expand access to treatment in Canada's First Nations, Inuit and Metis indigenous populations, where addiction is becoming a serious health problem.
RBCC Working to Ensure Opioid Addicts Can Get Treatment Following Surprising Study
BusinessWire - Wed Oct 21, 4:00AM CDT
Rainbow Coral Corp. (OTCBB:RBCC) has promised to double its efforts to make certain people addicted to opioids have access to treatment after a major university study showed nearly 80 percent are shut out of the system.
RBCC Partner n3D's Latest Article Shows Magnetic Bioprinting's Versatility and Promise
BusinessWire - Thu Oct 15, 4:00AM CDT
Rainbow Coral Corp. (OTCBB: RBCC) partner n3D has gotten a key article published on a recognized medical technology company's website, giving n3D and its considerable bioprinting expertise greater marketplace recognition and valuable exposure.
RBCC Ally n3D Inks Major Global Partnership Deal for Bioprinting Technology
BusinessWire - Wed Oct 07, 4:00AM CDT
Rainbow Coral Corp. (OTCBB:RBCC) partner Nano3D Biosciences (n3D) has signed a major worldwide agreement with leading biotech supplier Greiner Bio-One, continuing the innovative company's steady march to the marketplace.
RBCC: Customized Pills Show the Power and Potential of Personalized Medicine
ACCESSWIRE - Thu Jun 02, 7:27AM CDT
HENDERSON, NV / ACCESSWIRE / June 2, 2016 / Rainbow Coral Corp. (OTCQB: RBCC) continues to seek new opportunities and breakthroughs in personalized medicine and recent news from Singapore could offer the company the ground floor chance it has been looking for to become a leader in this rapidly growing field.
Upcoming Opioid Addiction Action in Congress Could Mean Opportunities for RBCC
ACCESSWIRE - Mon May 23, 4:01AM CDT
HENDERSON, NV / ACCESSWIRE / May 23, 2016 / Spurred by the ever-growing opioid addiction crisis, the U.S. Congress is now busy refining bipartisan legislation aimed at providing help and relief for those hooked on prescription drugs. This prospect could bode well for Rainbow Coral Corp. (OTCQB: RBCC) as it develops a new addiction treatment program utilizing Naltrexone, an anti-addiction medication.
Independent Forecast Justifies RBCC's Focus on Booming Personalized Medicine Market
ACCESSWIRE - Mon May 09, 9:04AM CDT
HENDERSON, NV / ACCESSWIRE / May 9, 2016 / Personalized (or precision) medicine continues a surge that shows no signs of stopping, and according to an independent research report the total market could top $88 billion within six years. The glowing report comes as welcome news for Rainbow Coral Corp. (OTCQB: RBCC), which has been active on several personalized medicine fronts recently, and bolsters the company's ambitions to someday be a leader in the field.
U.S. Drug Overdose Deaths Hit Record High, Opening Door for RBCC to Offer Solutions
ACCESSWIRE - Wed Apr 27, 4:00AM CDT
HENDERSON, NV / ACCESSWIRE / April 27, 2016 / Recently released overdose mortality statistics paint a grim picture of America's battle against prescription drug addiction, and while the portrait isn't pretty, Rainbow Coral Corp. (OTCQB: RBCC) believes the dire numbers may have at last spurred industry and government to find a workable answer.
RBCC Hails NYC Mayor's Bid to End the Big Apple's Opioid Addiction, Offers Assistance
BusinessWire - Wed Feb 10, 4:00AM CST
Rainbow Coral Corp. (OTCQB: RBCC) wants New York Mayor Bill De Blasio and his wife, Chirlane McCray, to know it's ready with an ample supply of Naltrexone to help their efforts to eradicate opioid addiction in America's biggest metropolis.
RBCC: Drug Approvals Show Personalized Medicine Gaining Favor with Feds and Public
BusinessWire - Thu Feb 04, 8:22AM CST
Rainbow Coral Corp. (OTCQB: RBCC) expects personalized medicine to grow even faster after examining the Federal Drug Administration's (FDA) list of drug approvals in 2015 - a list that includes a high percentage of pharmaceuticals intended for that rapidly rising market.
RBCC: Survey Shows Teen Substance Abuse Falling, But Much Work Remains
BusinessWire - Thu Jan 28, 8:06AM CST
Rainbow Coral Corp. (OTCQB: RBCC) is hailing a recent nationwide survey that shows substance abuse and addiction among American teens has dropped, but the company says a lot of hard work still lies ahead before the current crisis can be considered over.
Where Are We Headed - New Reports on World Moto, Greengro Technologies, Rainbow Coral, and Estacio Participacoes
ACCESSWIRE - Tue Jan 19, 8:16AM CST
NEW YORK, NY / ACCESSWIRE / January 19, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: World Moto Inc. (OTC: FARE), Greengro Technologies Inc. (OTC: GRNH), Rainbow Coral Corp. (OTC: RBCC) and Estacio Participacoes SA (OTC: ECPCY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Dynamics Driving Stunning Growth of Personalized Medicine Bode Well for RBCC
BusinessWire - Tue Jan 19, 4:00AM CST
A prominent doctor and healthcare expert says three key factors will drive continued future growth in personalized medicine and these elements spell opportunity for Rainbow Coral Corp. (OTCQB: RBCC) as it ramps up its efforts in this increasingly important field.
RBCC: Report Shows Personalized Medicine Market to More Than Double by 2022
BusinessWire - Wed Jan 13, 4:01AM CST
Rainbow Coral Corp. (OTCQB:RBCC) continues focusing on the personalized medicine market and expects its efforts to increase now that a prominent research study indicates the segment will grow to a nearly $2.5 billion industry by 2022. That figure represents almost a 150 percent increase in the market's current size of $1 billion in just a six-year period.
RBCC Aims to Increase Focus on Real 'Gateway Drug' Plaguing North America
BusinessWire - Mon Jan 11, 4:00AM CST
Rainbow Coral Corp. (OTCQB: RBCC) believes lawmakers and politicians have lost sight of a drug that far too often leads users to abuse and addiction, and unlike substances candidates and activists rail against, this one is perfectly legal.
RBCC Makes Great Strides in 2015, Looks Ahead to Eventful New Year
BusinessWire - Wed Jan 06, 4:22AM CST
Rainbow Coral Corp. (OTCQB:RBCC) President and CEO Kimberly Palmer issued the following open letter to stockholders today, reviewing the Company's 2015 achievements and providing a peek at what's to come in 2016:
RBCC: Need Grows for Affordable Treatment as Opioid Overdose Deaths Outpace Heroin
BusinessWire - Tue Dec 29, 7:21AM CST
Rainbow Coral Corp. (OTCQB: RBCC) intends to make 2016 a year where a sizable dent is finally made in the ongoing crisis concerning the alarming rate of opioid overdose deaths in the U.S. The company has already begun a search for partners and a location to open an inclusive, low-cost opioid addiction treatment center, and RBCC continues to explore options to obtain additional capital to fund such centers and other important anti-addiction research.
RBCC to Target Massive New Venture Capital Pouring Into American Healthcare
BusinessWire - Thu Dec 17, 8:28AM CST
A record amount of venture capital is flowing into the U.S. healthcare system. Rainbow Coral Corp. (OTCQB: RBCC) sees this influx as reaffirming its forward-looking personalized medicine strategy and plans to go after additional seed money to expand its market presence.
RBCC Offers Solutions to Growing Opioid Addiction Crisis That Kills 44 People per Day
BusinessWire - Mon Nov 23, 4:00AM CST
Rainbow Coral Corp. (OTCQB:RBCC) is heeding an urgent call to action put out by a prominent group of medical scientists looking to end the nation's expanding prescription opioid addiction epidemic - a problem that is now claiming an average of 44 lives per day.
RBCC Excited About Rapid Advances in Bioprinting
BusinessWire - Mon Nov 16, 4:00AM CST
Rainbow Coral Corp. (OTCQB:RBCC) and partner Nano3D Biosciences (n3D) are pondering potential future moves as researchers make tremendous strides in the field of bioprinting, meaning it may soon be possible to use additive manufacturing technology to engineer an entire human body.
RBCC Maps Out Strategy to Curb Addiction in Canada's Indigenous Communities
BusinessWire - Mon Nov 02, 4:00AM CST
Rainbow Coral Corp. (OTCBB: RBCC) has begun working on a way to increase use of the anti-addiction drug Naltrexone as well as to expand access to treatment in Canada's First Nations, Inuit and Metis indigenous populations, where addiction is becoming a serious health problem.
RBCC Working to Ensure Opioid Addicts Can Get Treatment Following Surprising Study
BusinessWire - Wed Oct 21, 4:00AM CDT
Rainbow Coral Corp. (OTCBB:RBCC) has promised to double its efforts to make certain people addicted to opioids have access to treatment after a major university study showed nearly 80 percent are shut out of the system.
RBCC Partner n3D's Latest Article Shows Magnetic Bioprinting's Versatility and Promise
BusinessWire - Thu Oct 15, 4:00AM CDT
Rainbow Coral Corp. (OTCBB: RBCC) partner n3D has gotten a key article published on a recognized medical technology company's website, giving n3D and its considerable bioprinting expertise greater marketplace recognition and valuable exposure.
RBCC Ally n3D Inks Major Global Partnership Deal for Bioprinting Technology
BusinessWire - Wed Oct 07, 4:00AM CDT
Rainbow Coral Corp. (OTCBB:RBCC) partner Nano3D Biosciences (n3D) has signed a major worldwide agreement with leading biotech supplier Greiner Bio-One, continuing the innovative company's steady march to the marketplace.
